Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropicamide 0.5% vs Cyclopentolate 0.5% for Cycloplegic Refraction in 4–6 Year Old Children
DRKS00009985Phase 4Completed
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tropicamide, cyclopentolate in ametropia, amblyopia, sponsored by Universitätsklinikum Erlangen. Started Feb 2016; status: completed.
02
Drugs
tropicamidecyclopentolate
03
Conditions
ametropiaamblyopia
Beyond the preview
Go deeper on DRKS00009985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00009985.